The effect of fluocinolone acetonide and 12-O-tetradecanoyl-phorbol-13-acetate on the binding and biological activity of epidermal growth factor in rat fibroblasts
- 1 January 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 4 (6) , 653-658
- https://doi.org/10.1093/carcin/4.6.653
Abstract
Synthetic glucocorticoids such as fluocinolone acetonide (FA) have been shown to be potent inhibitors of phorbol ester-mediated tumor promotion. When Rat-1 cells were incubated with FA the cells showed an increased capacity to bind [ 125 I]-epidermal growth factor (EGF) to surface receptors. A partial reversal of the ability of the phorbol ester tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate to reduce EGF binding to the class of high affinity receptors occurred following pre-exposure of cells to FA. The increased binding of EGF induced by FA resulted in a faster rate of degradation of EGF from the culture medium and reversed the inhibition of degradation caused by TPA. When EGF was present at low concentrations (<1 ng/ml), at which level FA was effective in increasing EGF degradation, FA-treated cells displayed a decreased induction of ornithine decarboxylase (ODC) activity and DNA synthesis. At higher EGF concentrations, the same level of ODC activity and DNA synthesis occurred in the presence or absence of FA, although some differences in the rates of induction were noted. These results support the hypothesis that the hyperplasia-inhibiting ability of glucocor-ticoid antipromoters may act by modulating EGF levels in the extracellular environment. However, our data also indicate that these antipromoters may act through other cellular mechanisms as well.This publication has 12 references indexed in Scilit:
- TUMOR PROMOTER-INDUCED INHIBITION OF EPIDERMAL GROWTH-FACTOR BINDING TO CULTURED MOUSE PRIMARY EPIDERMAL-CELLS1981
- Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number.Journal of Biological Chemistry, 1980
- ORNITHINE DECARBOXYLASE INDUCTION DURING G1 PROGRESSION OF NORMAL AND ROUS-SARCOMA VIRUS-TRANSFORMED CELLS1980
- Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factorProceedings of the National Academy of Sciences, 1979
- Glucocorticoids enhance the mitogenic action of insulin in serum‐free cultures of chick embryo cellsJournal of Cellular Physiology, 1979
- Alterations in Insulin Binding Induced by Changes in Vivo in the Levels of Glucocorticoids and Growth Hormone*Endocrinology, 1978
- Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell cultureProceedings of the National Academy of Sciences, 1978
- Glucocorticoid‐mediated alteration in growth factor binding and action: Analysis of the binding changeJournal of Supramolecular Structure, 1978
- 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.The Journal of cell biology, 1976
- Stimulation of ornithine decarboxylase synthesis and its control by polyamines in regenerating rat liver and cultured rat hepatoma cells.Journal of Biological Chemistry, 1976